Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $24.4 million.

  • Journey Medical's Shares Outstanding (Weighted Average) rose 17.61% to $24.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.4 million, marking a year-over-year increase of 17.61%. This contributed to the annual value of $20.9 million for FY2024, which is 12.87% up from last year.
  • As of Q3 2025, Journey Medical's Shares Outstanding (Weighted Average) stood at $24.4 million, which was up 4.65% from $23.3 million recorded in Q2 2025.
  • In the past 5 years, Journey Medical's Shares Outstanding (Weighted Average) ranged from a high of $24.4 million in Q3 2025 and a low of $15.8 million during Q1 2021.
  • For the 3-year period, Journey Medical's Shares Outstanding (Weighted Average) averaged around $20.5 million, with its median value being $20.0 million (2024).
  • Data for Journey Medical's Shares Outstanding (Weighted Average) shows a peak YoY climbed of 17.61% (in 2025) over the last 5 years.
  • Over the past 5 years, Journey Medical's Shares Outstanding (Weighted Average) (Quarterly) stood at $16.7 million in 2021, then climbed by 6.27% to $17.7 million in 2022, then grew by 4.54% to $18.5 million in 2023, then grew by 12.87% to $20.9 million in 2024, then rose by 17.61% to $24.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $24.4 million in Q3 2025, compared to $23.3 million in Q2 2025 and $23.1 million in Q1 2025.